| Andrew T Catanzaro, MD | |
|
5300 Elliott Dr, Ypsilanti, MI 48197-8632 | |
| (734) 434-6262 | |
| (734) 712-2820 |
| Full Name | Andrew T Catanzaro |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 29 Years |
| Location | 5300 Elliott Dr, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326028481 | NPI | - | NPPES |
| 7299241 | Other | MI | AETNA |
| 4620864 | Medicaid | MI | |
| 0H14989 | Other | MI | BCBS GROUP |
| 0813717 | Other | MI | BCBS INDIVIDUAL |
| 019913 | Other | MI | MIDWEST HEALTH PLAN |
| P00124950 | Other | MI | MEDICARE RAILROAD PTAN |
| 1436521 | Other | MI | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 080023 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| University Hospitals Ahuja Medical Center | Beachwood, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Hospitals Medical Group Inc | 4789682493 | 1466 |
News Archive
Until now, the mode of action of nitrogen-containing bisphosphonate (N-BP) cancer drugs, used to relieve bone pain and to prevent skeletal complications in bone metastasis, has been almost entirely unknown. Researchers writing in BioMed Central's open access journal Genome Biology have used 'barcoded' yeast mutants to identify new biological processes involved in the cellular response to N-BPs, opening up opportunities for the development of new anticancer drugs.
Portland State biologist Ken Stedman has received a $540,000 grant from NASA to study the evolution of viruses, which may shed light on how viruses form, adapt and infect hosts.
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers and their sensitivity to potential therapeutic agents.
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at the UH Cancer Center and his team have identified the role of the protein RSK2 in cancer cell migration, part of the process of cancer metastasis.
› Verified 9 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
Until now, the mode of action of nitrogen-containing bisphosphonate (N-BP) cancer drugs, used to relieve bone pain and to prevent skeletal complications in bone metastasis, has been almost entirely unknown. Researchers writing in BioMed Central's open access journal Genome Biology have used 'barcoded' yeast mutants to identify new biological processes involved in the cellular response to N-BPs, opening up opportunities for the development of new anticancer drugs.
Portland State biologist Ken Stedman has received a $540,000 grant from NASA to study the evolution of viruses, which may shed light on how viruses form, adapt and infect hosts.
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers and their sensitivity to potential therapeutic agents.
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at the UH Cancer Center and his team have identified the role of the protein RSK2 in cancer cell migration, part of the process of cancer metastasis.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew T Catanzaro, MD 5300 Elliott Dr, Ypsilanti, MI 48197-8632 Ph: (734) 434-6262 | Andrew T Catanzaro, MD 5300 Elliott Dr, Ypsilanti, MI 48197-8632 Ph: (734) 434-6262 |
News Archive
Until now, the mode of action of nitrogen-containing bisphosphonate (N-BP) cancer drugs, used to relieve bone pain and to prevent skeletal complications in bone metastasis, has been almost entirely unknown. Researchers writing in BioMed Central's open access journal Genome Biology have used 'barcoded' yeast mutants to identify new biological processes involved in the cellular response to N-BPs, opening up opportunities for the development of new anticancer drugs.
Portland State biologist Ken Stedman has received a $540,000 grant from NASA to study the evolution of viruses, which may shed light on how viruses form, adapt and infect hosts.
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers and their sensitivity to potential therapeutic agents.
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at the UH Cancer Center and his team have identified the role of the protein RSK2 in cancer cell migration, part of the process of cancer metastasis.
› Verified 9 days ago
Bretton Lee Schloesser, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Dr. Kelly Perry Apple, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 Fax: 734-712-3855 | |
Rajiv Doddamani, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 4001, Ypsilanti, MI 48197 Phone: 734-834-4270 | |
Dr. James Paolo Purtell, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Dr, Suite 2111, Ypsilanti, MI 48197 Phone: 734-712-5552 | |
Kory Ashton Strong, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: Iha Hospital Medicine Services, 5301 E Huron River Drive, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Michael Sanson, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5361 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-1300 Fax: 734-222-3665 | |
Dr. Stephanie Joy-kraftson Hoffman, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Iha Hematology Oncology, 5303 Elliott Drive, Suite 210, Ypsilanti, MI 48197 Phone: 734-712-1000 Fax: 734-712-1012 |